Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Posey

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2003
Borrelia oxidative stress response regulator, BosR: a distinctive Zn-dependent transcriptional activatorJulie A Boylan, James E Posey, Frank C Gherardini
Clinical Microbiology Reviews|November 1, 2019
Tuberculosis Vaccine Development: Progress in Clinical EvaluationSuraj B Sable, James E Posey, Thomas J Scriba
Journal of Bacteriology|February 3, 2006
Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatisJames E Posey, Thomas M Shinnick, Frederick D Quinn
Frontiers in Immunology|April 6, 2026
Methodology for a freshly engineered or cryo-preserved 3D tuberculoma bioplatform for studying tuberculosis biology and high-content screening of therapeuticsSuraj B Sable, Allison Kline, Wen Li, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosisAnalise Z Reeves, Patricia J Campbell, Melisa J Willby, et al.
Plos One|July 5, 2012
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutationsSeidu Malik, Melisa Willby, David Sikes, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosisMelisa Willby, R David Sikes, Seidu Malik, et al.
Plos One|November 25, 2014
Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in miceSubhadra Nandakumar, Sunil Kannanganat, James E Posey, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2009
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosisM Analise Zaunbrecher, R David Sikes, Beverly Metchock, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosisAngela M Starks, Aysel Gumusboga, Bonnie B Plikaytis, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2003
Borrelia oxidative stress response regulator, BosR: a distinctive Zn-dependent transcriptional activatorJulie A Boylan, James E Posey, Frank C Gherardini
Clinical Microbiology Reviews|November 1, 2019
Tuberculosis Vaccine Development: Progress in Clinical EvaluationSuraj B Sable, James E Posey, Thomas J Scriba
Journal of Bacteriology|February 3, 2006
Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatisJames E Posey, Thomas M Shinnick, Frederick D Quinn
Frontiers in Immunology|April 6, 2026
Methodology for a freshly engineered or cryo-preserved 3D tuberculoma bioplatform for studying tuberculosis biology and high-content screening of therapeuticsSuraj B Sable, Allison Kline, Wen Li, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosisAnalise Z Reeves, Patricia J Campbell, Melisa J Willby, et al.
Plos One|July 5, 2012
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutationsSeidu Malik, Melisa Willby, David Sikes, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosisMelisa Willby, R David Sikes, Seidu Malik, et al.
Plos One|November 25, 2014
Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in miceSubhadra Nandakumar, Sunil Kannanganat, James E Posey, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2009
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosisM Analise Zaunbrecher, R David Sikes, Beverly Metchock, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosisAngela M Starks, Aysel Gumusboga, Bonnie B Plikaytis, et al.
Pageof 5